INGN
Inogen Inc
NASDAQ · Healthcare · Medical - Devices · US
$5.14
+0.19%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.11
- Revenue estimate
- $92.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.15
- Revenue actual
- $95.1M
- Revenue estimate
- $95.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +5.1%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.15 | -$0.14 | Beat 8.69% | $95.1M |
| May 7, 2026 | -$0.24 | -$0.30 | Miss -25.00% | $85.1M |
| Feb 24, 2026 | -$0.36 | -$0.26 | Beat 27.78% | $81.7M |
| Nov 5, 2025 | -$0.22 | -$0.20 | Beat 9.09% | $92.4M |
| Aug 7, 2025 | -$0.22 | -$0.15 | Beat 31.82% | $92.3M |
| May 7, 2025 | -$0.52 | -$0.25 | Beat 51.92% | $82.3M |
| Nov 7, 2024 | -$0.49 | -$0.25 | Beat 48.98% | $88.8M |
| Feb 27, 2024 | -$0.62 | -$1.14 | Miss -83.87% | $75.9M |
| May 4, 2023 | -$0.77 | -$0.63 | Beat 18.18% | $72.2M |
| Feb 23, 2023 | -$0.60 | -$0.57 | Beat 5.00% | $88.1M |
| Nov 2, 2022 | -$0.41 | -$0.18 | Beat 56.10% | $105.4M |
| Aug 4, 2022 | -$0.40 | -$0.02 | Beat 95.00% | $103.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026